Published in Am J Respir Crit Care Med on November 14, 2002
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet (2013) 4.75
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83
Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS One (2009) 3.53
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother (2009) 2.92
Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol (2009) 2.58
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med (2012) 2.44
Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev (2010) 2.32
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol (2010) 2.19
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros (2010) 1.93
Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis (2009) 1.91
Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol (2009) 1.91
Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis (2011) 1.84
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol (2005) 1.83
Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. Am J Respir Crit Care Med (2015) 1.77
Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis (2008) 1.76
Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis (2008) 1.69
Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol (2007) 1.57
Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med (2014) 1.51
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr Radiol (2005) 1.48
Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. Am J Respir Crit Care Med (2003) 1.43
First isolations of Segniliparus rugosus from patients with cystic fibrosis. J Clin Microbiol (2007) 1.33
Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J Clin Microbiol (2006) 1.25
Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med (2012) 1.24
High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis (2014) 1.21
Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation. Proc Natl Acad Sci U S A (2014) 1.20
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Chemother (2008) 1.19
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax (2006) 1.18
Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (2004) 1.17
Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year period. J Clin Microbiol (2006) 1.17
Epidemiology and Ecology of Opportunistic Premise Plumbing Pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa. Environ Health Perspect (2015) 1.14
Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol (2008) 1.12
The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. Eur J Clin Microbiol Infect Dis (2012) 1.12
Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest (2011) 1.10
Isolation of a novel strain of Mycobacterium iranicum from a woman in the United States. J Clin Microbiol (2012) 1.10
Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol (2012) 1.10
Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med (2013) 1.09
Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med (2014) 1.06
Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis (2011) 1.05
Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol (2009) 1.01
Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis. J Clin Microbiol (2005) 1.01
Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. PLoS One (2012) 0.99
Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report. J Med Case Rep (2011) 0.97
Mycobacterium abscessus glycopeptidolipid prevents respiratory epithelial TLR2 signaling as measured by HβD2 gene expression and IL-8 release. PLoS One (2011) 0.96
Mycobacterium abscessus multispacer sequence typing. BMC Microbiol (2013) 0.95
Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2014) 0.95
Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis (2013) 0.95
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc (2014) 0.94
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. Antimicrob Agents Chemother (2012) 0.93
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrob Agents Chemother (2015) 0.93
Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int Arch Med (2008) 0.93
Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Curr Infect Dis Rep (2010) 0.92
Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med (2013) 0.90
Rapid identification of mycobacteria from smear-positive sputum samples by nested PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (2008) 0.90
Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. J Clin Microbiol (2013) 0.90
Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol (2011) 0.90
Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest (2009) 0.89
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science (2016) 0.89
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One (2016) 0.88
Pulmonary Tuberculosis in a Patient with Cystic Fibrosis. N Am J Med Sci (2015) 0.87
Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc (2014) 0.86
Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients. J Clin Microbiol (2014) 0.85
Mycobacteriophage-drived diversification of Mycobacterium abscessus. Biol Direct (2014) 0.85
Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice. Infect Immun (2014) 0.85
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis. Respir Res (2014) 0.85
A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia. BMC Infect Dis (2014) 0.85
Molecular longitudinal tracking of Mycobacterium abscessus spp. during chronic infection of the human lung. PLoS One (2013) 0.84
Rough colony morphology of Mycobacterium massiliense Type II genotype is due to the deletion of glycopeptidolipid locus within its genome. BMC Genomics (2013) 0.83
Mycobacterium abscessus Complex Identification with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol (2015) 0.83
Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients. J Clin Microbiol (2013) 0.83
Non-tuberculous mycobacteria in cystic fibrosis. J R Soc Med (2012) 0.82
Identification and management of unusual pathogens in cystic fibrosis. J R Soc Med (2008) 0.82
Mycobacterial pulmonary infections in patients with idiopathic pulmonary fibrosis. J Korean Med Sci (2012) 0.82
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis. Biomed Res Int (2015) 0.82
A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections. Semin Immunopathol (2016) 0.81
Nontuberculous mycobacteria and the lung: from suspicion to treatment. Lung (2010) 0.81
The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease. Lung (2014) 0.81
Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients. Ann Clin Microbiol Antimicrob (2014) 0.80
Inhibition of the β-lactamase BlaMab by avibactam improves the in vitro and in vivo efficacy of imipenem against Mycobacterium abscessus. Antimicrob Agents Chemother (2017) 0.80
The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol (2016) 0.80
Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications. BMC Genomics (2016) 0.79
Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis. Med Microbiol Immunol (2003) 0.78
Mycobacterium abscessus morphotype comparison in a murine model. PLoS One (2015) 0.78
Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. BMC Infect Dis (2016) 0.78
The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection. Front Cell Infect Microbiol (2017) 0.77
Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacterium abscessus Subspecies According to Whole-Genome Sequencing. J Clin Microbiol (2016) 0.77
Mycobacterium abscessus-Induced Granuloma Formation Is Strictly Dependent on TNF Signaling and Neutrophil Trafficking. PLoS Pathog (2016) 0.77
Principal component analysis of MALDI TOF MS mass spectra separates M. abscessus (sensu stricto) from M. massiliense isolates. BMC Microbiol (2016) 0.77
The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. Mediators Inflamm (2012) 0.77
Vaccine strategies against cystic fibrosis pathogens. Hum Vaccin Immunother (2016) 0.77
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus. Future Microbiol (2017) 0.77
High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy. Eur Radiol (2012) 0.77
Mycobacterium abscessus WhiB7 regulates a species -specific repertoire of genes to confer extreme antibiotic resistance. Antimicrob Agents Chemother (2017) 0.76
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev (2006) 7.85
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev (2002) 7.15
Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med (2005) 5.51
Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med (2006) 5.37
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet (2011) 4.70
Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med (2003) 4.33
Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation (2007) 4.17
Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control (2005) 4.02
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev (2008) 3.93
The accuracy of noninvasive hemoglobin monitoring using the radical-7 pulse CO-Oximeter in children undergoing neurosurgery. Anesth Analg (2012) 3.71
SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol (2010) 3.44
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell (2012) 3.21
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res (2005) 3.08
Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet (2011) 3.02
Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2012) 3.01
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res (2006) 3.00
Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA (2010) 2.99
Genetic defects in ciliary structure and function. Annu Rev Physiol (2007) 2.94
Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol (2003) 2.93
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother (2009) 2.92
DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med (2006) 2.92
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax (2011) 2.84
Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2012) 2.75
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med (2009) 2.71
S100A4, a mediator of metastasis. J Biol Chem (2005) 2.68
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin Cancer Res (2006) 2.68
Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol (2009) 2.58
Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis (2008) 2.56
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol (2002) 2.51
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine (2011) 2.43
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 2.41
Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis (2003) 2.37
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2006) 2.34
Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol (2009) 2.31
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clin Cancer Res (2007) 2.28
Statistical tests with accurate size and power for balanced linear mixed models. Stat Med (2007) 2.27
Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia. Am J Respir Crit Care Med (2005) 2.25
Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med (2011) 2.21
Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res (2010) 2.19
Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2002) 2.15
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet (2012) 2.14
Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol (2011) 2.13
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res (2006) 2.11
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects. Am J Hum Genet (2009) 2.10
Exertional desaturation as a predictor of rapid lung function decline in COPD. Respiration (2012) 2.09
Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature (2009) 2.05
Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis (2004) 2.01
Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer (2009) 2.01
Impact of vaginal-rectal ultrasound examinations with covered and low-level disinfected transducers on infectious transmissions in france. Infect Control Hosp Epidemiol (2014) 1.98
Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol (2010) 1.95
Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet (2013) 1.90
Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother (2002) 1.89
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
An F-box gene linked to the self-incompatibility (S) locus of Antirrhinum is expressed specifically in pollen and tapetum. Plant Mol Biol (2002) 1.83
Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med (2006) 1.80
What is cystic fibrosis? N Engl J Med (2002) 1.76
Room decontamination with UV radiation. Infect Control Hosp Epidemiol (2010) 1.76
Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J Clin Microbiol (2005) 1.75
Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol (2009) 1.70
Sequence-based identification of aerobic actinomycetes. J Clin Microbiol (2004) 1.70
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol (2007) 1.67
Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am J Psychiatry (2005) 1.66
Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet (2012) 1.64
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol (2004) 1.64
Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med (2006) 1.63
Real longitudinal data analysis for real people: building a good enough mixed model. Stat Med (2010) 1.61
Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol (2004) 1.61
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. J Clin Oncol (2008) 1.61
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med (2012) 1.59
The benefits of surface disinfection. Am J Infect Control (2004) 1.58
Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol (2002) 1.58
The F-box protein AhSLF-S2 physically interacts with S-RNases that may be inhibited by the ubiquitin/26S proteasome pathway of protein degradation during compatible pollination in Antirrhinum. Plant Cell (2004) 1.54
Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. Am J Hum Genet (2012) 1.53
Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics (2009) 1.52
Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology (2008) 1.52
Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol (2004) 1.51
Primary care utilization and colorectal cancer incidence and mortality among Medicare beneficiaries: a population-based, case-control study. Ann Intern Med (2013) 1.51
Sun protection at elementary schools: a cluster randomized trial. J Natl Cancer Inst (2010) 1.50
The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosis. Genet Med (2002) 1.49
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest (2005) 1.49
Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc (2013) 1.49
Early-life soy exposure and gender-role play behavior in children. Environ Health Perspect (2011) 1.49
Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol (2011) 1.48
Trombone player's lung: a probable new cause of hypersensitivity pneumonitis. Chest (2010) 1.48
The F-box protein AhSLF-S2 controls the pollen function of S-RNase-based self-incompatibility. Plant Cell (2004) 1.47
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev (2006) 1.45
An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis (2002) 1.44
Magnetic ratchet for three-dimensional spintronic memory and logic. Nature (2013) 1.44